Table 1

Model parameter values

Variable

Age group

Value (range)

Source


Population size

0-2

63,025

2006 Census [42]


3-4

42,260


5-17

322,670


18-24

203,500


25-54

975,875


55-64

237,795


≥65

271,455


Total

2,116,580


Latent period (days)

All

3 (2-4)

Tuite et al. 2010 [22]


Initial asymptomatic infectious period (in all infected individuals) (days)

All

1

Liao et al. 2010 [43]


Total duration of infectiousness (days)

All

7 (5-7)

Tuite et al. 2010 [22]; De Serres [44]


Basic Reproduction number (R0)

All

1.4 (1.2-1.8)

Pourbohloul et al. 2009 [27]


Proportion of population with pre-existing immunity

≥55

0.5

Centers for Disease Control and Prevention 2009 [13]; Fisman et al. 2009 [6]


Vaccine efficacy

All

0.9 (0.5-1)

Product Monograph Arepanrix(tm) H1N1 [45]; Waddington et al., 2010 [46]


Proportion of infected individuals who self-isolate

All

0.1 (0.1-0.6)

Assumption


Mortality (per 100,000 infections)

0-2

30

Donaldson et al. 2009 [47]


2-4

27


5-17

11


18-24

12


25-54

30


55-64

65


≥65

980


Conway et al. BMC Public Health 2011 11:932   doi:10.1186/1471-2458-11-932

Open Data